Literature DB >> 10440268

Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes.

I Kim1, A M Ryan, R Rohan, S Amano, S Agular, J W Miller, A P Adamis.   

Abstract

PURPOSE: The expression of vascular endothelial growth factor (VEGF) and its high-affinity receptors VEGFR-1 and VEGFR-2 was investigated in normal eyes.
METHODS: Monkey and rat eyes were surgically removed in animals under deep anesthesia and immediately prepared for study. Ocular VEGF, VEGFR-1, and VEGFR-2 expression was studied using a combination of in situ hybridization, northern blot analysis, immunohistochemistry, immunoassay, and reverse transcription-polymerase chain reaction.
RESULTS: Steady state VEGF mRNA levels were detected in the normal vascularized ocular tissues of the monkey: the conjunctiva, iris, retina, and the choroid-retinal pigment epithelial complex. VEGF121 and VEGF165 were the major isoforms identified. VEGF protein was detected in the conjunctiva, retina, and the choroid-retinal pigment epithelial complex. Retinal VEGF mRNA localized to the ganglion, inner nuclear, and retinal pigment epithelial cell layers. VEGF protein localized to these same layers and to the cones of monkey retina. VEGFR-1 and VEGFR-2 mRNAs were detected in normal monkey iris, retina, and the choroid-retinal pigment epithelial complex. In both monkey and rat eyes, VEGFR-1 and VEGFR-2 mRNAs were localized to the inner nuclear layer of the retina.
CONCLUSIONS: VEGF, VEGFR-1, and VEGFR-2 are constitutively expressed in the vascularized tissues of normal eyes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440268

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  52 in total

1.  Associations between dietary flavonoids and retinal microvasculature in older adults.

Authors:  Bamini Gopinath; Gerald Liew; Joshua R Lewis; Nicola P Bondonno; Catherine P Bondonno; George Burlutsky; Jonathan M Hodgson; Paul Mitchell
Journal:  Eur J Nutr       Date:  2019-11-25       Impact factor: 5.614

Review 2.  Vascular endothelial growth factor biology: clinical implications for ocular treatments.

Authors:  R B Bhisitkul
Journal:  Br J Ophthalmol       Date:  2006-12       Impact factor: 4.638

3.  Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.

Authors:  M S Spitzer; B Wallenfels-Thilo; A Sierra; E Yoeruek; S Peters; S Henke-Fahle; K U Bartz-Schmidt; P Szurman
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

Review 4.  The treatment of wet age-related macular degeneration.

Authors:  Antonia M Joussen; Norbert Bornfeld
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

5.  Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

Authors:  C Schwesinger; C Yee; R M Rohan; A M Joussen; A Fernandez; T N Meyer; V Poulaki; J J Ma; T M Redmond; S Liu; A P Adamis; R J D'Amato
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.

Authors:  T G Sheidow; P L Hooper; C Crukley; J Young; J G Heathcote
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

Review 7.  Anti-vascular endothelial growth factor therapy for diabetic macular edema.

Authors:  David S Boyer; J Jill Hopkins; Jonathan Sorof; Jason S Ehrlich
Journal:  Ther Adv Endocrinol Metab       Date:  2013-12       Impact factor: 3.565

8.  Active HIF-1 in the normal human retina.

Authors:  John M Hughes; Arjan J Groot; Petra van der Groep; René Sersansie; Marc Vooijs; Paul J van Diest; Cornelis J F Van Noorden; Reinier O Schlingemann; Ingeborg Klaassen
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

9.  Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation.

Authors:  Alexandros A Rouvas; Thanos D Papakostas; Ioannis D Ladas; Ioannis Vergados
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-24       Impact factor: 3.117

10.  Effects of vascular endothelial cell growth factor on fibrovascular ingrowth into rabbits hydroxyapatite orbital implant.

Authors:  Hong Zhang; Guigang Li; Caini Ji; Hua He; Junming Wang; Weikun Hu; Hua Wu; Jing Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.